Inclusion Criteria:
  -  Diagnosis of CD for at least 3 months prior to baseline
  -  Confirmed diagnosis of moderate to severe CD as assessed by SF, AP score, and SES-CD
  -  Demonstrated intolerance, loss of response or inadequate response to conventional or to biologic therapy for CD
  -  If female, subject must meet the contraception recommendations
Exclusion Criteria:
  -  Have a current diagnosis of ulcerative colitis, inflammatory bowel disease-unclassified (IBD-U) (formerly known as indeterminate colitis), abdominal or perianal abscess or short bowel syndrome
  -  Have a stoma or ostomy
  -  Have had a bowel resection within 6 months, or any kind of intra-abdominal or extra abdominal surgery within 3 months of baseline
  -  Have ever received any monoclonal antibodies binding IL-23